5.51 USD
↗ 0.08 (1.47%)AT CLOSE (11:59 AM EDT)
Atea Pharmaceuticals, Inc. Common Stock
AVIRNASDAQ • USD
5.52
↗ 0.01 (0.09%)
POST MARKET (AS OF 07:37 PM EDT)
Post Market
AS OF 07:37 PM EDT
5.52
↗ 0.01 (0.09%)
Market: CLOSED
Atea Pharmaceuticals, Inc. Common Stock (AVIR) trades at $5.51 per share. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, AVIR appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Aug 26, 2026.
Open?$5.43
High?$5.59
Low?$5.30
Prev. Close?$5.43
Volume?214.1K
Avg. Volume?320.7K
VWAP?$5.46
Rel. Volume?0.67x
Bid / Ask
Bid?$4.70 × 2.5K
Ask?$5.70 × 100
Spread?$1.00
Midpoint?$5.20
Valuation & Ratios
Market Cap?441.9M
Shares Out?80.2M
Float?60.5M
Float %?75.5%
P/E Ratio?N/A
P/B Ratio?2.16
EPS?-$2.06
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Employees
55
Market Cap
435.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-10-30
Address
225 FRANKLIN STREET
BOSTON, MA 02110
Phone: (857) 284-8891
BOSTON, MA 02110
Phone: (857) 284-8891
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?94
Momentum?50
Short Sent.?28
Piotroski F-Score?0/9Weak
Altman Z-Score?4.23Safe
Confidence?48%Low
Short InterestVery High
Short % of Float?12.69%High
Short Interest?7.7M
Days to Cover?26.6
Free Float60.5M
Avg Daily Volume288.3K
Settlement Date2026-08-14
Financial Health
Current Ratio?8.13Strong
Quick Ratio?8.13Strong
Cash Ratio?2.72Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.16CHEAP▾
Peers100
S&P71
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-81.0%WEAK▾
S&P3
ROA?-71.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-152073000
Enterprise Value?$365.4M
Fundamentals ratios updated end of day